Q1 2025 Vireo Growth Inc Earnings Call Transcript
Key Points
- First quarter revenue increased 1.9% year over year to $24.5 million, indicating growth in core markets.
- Continued growth was observed in Maryland, with stable performance in Minnesota.
- Sales of wholesale products from the indoor facility in New York commenced in Q1 and are ramping up in Q2.
- The pending merger transactions are expected to enhance profitability with positive net income.
- The company maintains a healthy financial position with $86.3 million in cash on hand and no current debt.
- First quarter revenue was down slightly on a sequential basis compared to the fourth quarter.
- There were expected declines in New York medical sales, impacting overall performance.
- GAAP gross margin performance was flat compared to the previous year, affected by one-time fees.
- Property income decreased significantly from $4.7 million in Q1 of last year to $1.9 million.
- Operating income was impacted by one-time transaction expenses of $1.2 million related to pending mergers.
Good morning and welcome to Vireo Growth Inc's first quarter 2025 results call.
(operator Instructions)
I will now hand the call over to Chief Executive Officer John Maarakki. Please go ahead, sir.
Thank you. Good morning, everyone. I will begin with a brief summary of our Q1 performance as we are marching towards closing our pending merger transactions, and then Tyson will provide some extra detail on the financials.
Our first quarter results were in line with our expectations for various core markets. First quarter revenue increased 1.9% year over year to 24.5 million and was down slightly sequentially compared to the fourth quarter.
We experienced continued growth in Maryland, stable performance in Minnesota, and expected declines in New York medical sales.
Sales of wholesale products from our indoor facility in New York commenced in Q1 and have continued to ramp meaningfully in Q2.
We are progressing towards closing our merger transactions
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
